Single ascending dose (SAD) study to evaluate the safety and tolerability of XEN-101 in healthy participants. Multiple ascending dose (MAD) study to evaluate the safety and tolerability of XEN-101 in healthy participants.
The goal of this study is to assess the safety and tolerability of single and multiple ascending doses of XEN-101